摘要
目的采用SERODIA—MYCOII肺炎支原体诊断试剂盒检测患者血清中肺炎支原体(Mp)抗体效价,探讨其在临床上的应用价值。方法采集患者静脉血,血清作倍比稀释,用日本富士肺炎支原体诊断试剂盒SERODIA—MYCOII作颗粒凝集试验,并对测定结果进行分析。结果1164例被检血清中,血清抗体阳性者505例(效价〉1:40),阳性率为43.27%。〈5岁组阳性率为23.85%,且抗体效价较低,以1:40和1:80多见;5—14岁阳性率为60.57%;〉14岁阳性率为35.74%,且抗体效价较高,多在1:160以上。结论SERODIA—MYCOII检测血清中Mp抗体效价具有敏感性高、特异性强、重复性好等特点,值得临床推广作为实验室筛查Mp感染的常规方法。
Objective In order to investigate the application of its clinical study, mycoplasma pneumonia (Mp) antibody titers in patients were detected with SERODIA-MYCOII kit. Methods Patients' blood serum were collected and diluted for the times with Mycoplasma pneumoniae SERODIA-MYCOII kit produced by Japan's Fujirebio for particle agglutination test, and results were analyzed, Results The results of 1, 164 cases, 505 cases were positive (titer〉 1: do), the positive rate was 43.27 %. Below 5 years old group, the positive rate was 23.85 %, and the antibody titers of 1: 40 and 1:80 were predominant and its titers were lower. In 5 to 14-year-old group, the positive rate was 60.57%. In above 14-year-old group, the positive rate was 35.74 %, and the antibody titers were more than 1: 160. Conclusions SERODIA-MYCOII Mp in serum antibody titers with high sensitivity and specificity, repeatable, and other characteristics, it is worth promoting as a clinical laboratory screening Mp infection of conventional methods.
出处
《国际医药卫生导报》
2009年第16期88-90,共3页
International Medicine and Health Guidance News
关键词
肺炎支原体
抗体
滴度
临床应用
Mycoplasma pneumoniae
Antibody titer
Clinical application